Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (15)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Iga, J.-I.
Right arrow Articles by Ohmori, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iga, J.-I.
Right arrow Articles by Ohmori, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Alcohol and Alcoholism Vol. 36, No. 6, pp. 553-555, 2001
© 2001 Medical Council on Alcohol

A CASE OF KORSAKOFF'S SYNDROME IMPROVED BY HIGH DOSES OF DONEPEZIL

Jun-Ichi Iga,*, Makoto Araki, Yasuhito Ishimoto and Tetsuro Ohmori

Department of Neuropsychiatry, University of Tokushima School of Medicine, 3-18-15 Kuramoto-Cho, Tokushima-Shi-770 8503, Japan

Received 14 February 2001; first review notified 9 April 2001; accepted 21 May 2001

— We present a case of Korsakoff's syndrome that was successfully treated with high doses of donepezil, an inhibitor of acetylcholine esterase, known to retard the progress of symptoms in Alzheimer's disease. The patient was a 46-year-old married Japanese woman who began to drink alcohol after she married. After several years of drinking she developed typical symptoms of the Korsakoff syndrome. Donepezil was started after treatment with thiamine or thiamine plus fluvoxamine had failed. Her amnestic symptoms as well as her quality of life improved markedly during donepezil treatment. Inhibition of acetylcholine esterase may be an effective treatment for Korsakoff's syndrome.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Alcohol AlcoholHome page
M. COCHRANE, A. COCHRANE, P. JAUHAR, and E. ASHTON
ACETYLCHOLINESTERASE INHIBITORS FOR THE TREATMENT OF WERNICKE-KORSAKOFF SYNDROME-THREE FURTHER CASES SHOW RESPONSE TO DONEPEZIL
Alcohol Alcohol., March 1, 2005; 40(2): 151 - 154.
[Abstract] [Full Text] [PDF]

Home page
 J PsychopharmacolHome page
A. R. Lingford-Hughes, S. Welch, and D. J. Nutt
Evidence-Based Guidelines for the Pharmacological Management of Substance Misuse, Addiction and Comorbidity: Recommendations from the British Association for Psychopharmacology
J Psychopharmacol, September 1, 2004; 18(3): 293 - 335.
[PDF]

Home page
 PsychosomaticsHome page
B. K. Phillips, M. V. Ingram, and G. G. Grammer
Wernicke-Korsakoff Syndrome and Galantamine
Psychosomatics, August 1, 2004; 45(4): 366 - 368.
[Full Text] [PDF]

Home page
 PsychosomaticsHome page
P. B. Rosenberg and R. Rosse
Impulsive Suicide Attempts by a Patient With Alcoholic Dementia
Psychosomatics, October 1, 2003; 44(5): 415 - 416.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.